166 related articles for article (PubMed ID: 27650585)
21. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
Miyahara M; Tanuma J; Sugihara K; Semba I
Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
[TBL] [Abstract][Full Text] [Related]
22. Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway.
Sun Q; Zhang T; Xiao Q; Mei B; Zhang X
Bioengineered; 2022 Mar; 13(3):6500-6508. PubMed ID: 35220896
[TBL] [Abstract][Full Text] [Related]
23. Differential immunohistochemical expression profiles of perlecan-binding growth factors in epithelial dysplasia, carcinoma in situ, and squamous cell carcinoma of the oral mucosa.
Hasegawa M; Cheng J; Maruyama S; Yamazaki M; Abé T; Babkair H; Saito C; Saku T
Pathol Res Pract; 2016 May; 212(5):426-36. PubMed ID: 26965914
[TBL] [Abstract][Full Text] [Related]
24. Autocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells.
Matsuura M; Onimaru M; Yonemitsu Y; Suzuki H; Nakano T; Ishibashi H; Shirasuna K; Sueishi K
Am J Pathol; 2009 Oct; 175(4):1709-21. PubMed ID: 19779139
[TBL] [Abstract][Full Text] [Related]
25. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
26. [Establishment of CoCl2 induced hypoxic cell model of oral squamous cell carcinoma and a preliminary study on the biological behaviour change].
Han S; Han W; Ni Y; Wang Z; Hu Q
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Mar; 50(3):173-7. PubMed ID: 26081859
[TBL] [Abstract][Full Text] [Related]
27. Deguelin--an inhibitor to tumor lymphangiogenesis and lymphatic metastasis by downregulation of vascular endothelial cell growth factor-D in lung tumor model.
Hu J; Ye H; Fu A; Chen X; Wang Y; Chen X; Ye X; Xiao W; Duan X; Wei Y; Chen L
Int J Cancer; 2010 Nov; 127(10):2455-66. PubMed ID: 20162567
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of canstatin in alkali burn-induced corneal neovascularization.
Wang Y; Yin H; Chen P; Xie L; Wang Y
Ophthalmic Res; 2011; 46(2):66-72. PubMed ID: 21242701
[TBL] [Abstract][Full Text] [Related]
29. Sunitinib inhibits inflammatory corneal lymphangiogenesis.
Detry B; Blacher S; Erpicum C; Paupert J; Maertens L; Maillard C; Munaut C; Sounni NE; Lambert V; Foidart JM; Rakic JM; Cataldo D; Noël A
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3082-93. PubMed ID: 23580490
[TBL] [Abstract][Full Text] [Related]
30. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model.
Wen J; Fu AF; Chen LJ; Xie XJ; Yang GL; Chen XC; Wang YS; Li J; Chen P; Tang MH; Shao XM; Lu Y; Zhao X; Wei YQ
Int J Cancer; 2009 Jun; 124(11):2709-18. PubMed ID: 19219913
[TBL] [Abstract][Full Text] [Related]
31. High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma.
Sasahira T; Kirita T; Oue N; Bhawal UK; Yamamoto K; Fujii K; Ohmori H; Luo Y; Yasui W; Bosserhoff AK; Kuniyasu H
Cancer Sci; 2008 Sep; 99(9):1806-12. PubMed ID: 18616526
[TBL] [Abstract][Full Text] [Related]
32. [Expression and prognostic value of VEGF-C and lymphangeogenesis in lung adenocarcinoma and squamous cell carcinoma].
Dai X; Wang W; Shen-Tu Y; Zhang J
Zhongguo Fei Ai Za Zhi; 2011 Oct; 14(10):774-9. PubMed ID: 22008106
[TBL] [Abstract][Full Text] [Related]
33. Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B.
Wang Z; Lv J; Zhang T
Oncol Rep; 2015 May; 33(5):2468-76. PubMed ID: 25778843
[TBL] [Abstract][Full Text] [Related]
34. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
[TBL] [Abstract][Full Text] [Related]
35. VEGF mediated signaling in oral cancer.
Lin X; Khalid S; Qureshi MZ; Attar R; Yaylim I; Ucak I; Yaqub A; Fayyaz S; Farooqi AA; Ismail M
Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):64-68. PubMed ID: 28145862
[TBL] [Abstract][Full Text] [Related]
36. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
[TBL] [Abstract][Full Text] [Related]
37. Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma.
Morita Y; Hata K; Nakanishi M; Omata T; Morita N; Yura Y; Nishimura R; Yoneda T
Clin Exp Metastasis; 2015 Oct; 32(7):739-53. PubMed ID: 26319373
[TBL] [Abstract][Full Text] [Related]
38. Effect of local hyperthermia on lymphangiogenic factors VEGF-C and -D in a nude mouse xenograft model of tongue squamous cell carcinoma.
Liang X; Zhou H; Liu X; He Y; Tang Y; Zhu G; Zheng M; Yang J
Oral Oncol; 2010 Feb; 46(2):111-5. PubMed ID: 20036606
[TBL] [Abstract][Full Text] [Related]
39. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
He GA; Luo JX; Zhang TY; Hu ZS; Wang FY
Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609
[TBL] [Abstract][Full Text] [Related]
40. Vascular Endothelial Growth Factor A (VEGF-A) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) as Potential Biomarkers for Oral Squamous Cell Carcinoma: A Sri Lankan Study.
Edirisinghe ST; Weerasekera M; De Silva DK; Devmini MT; Pathmaperuma S; Wijesinghe GK; Nisansala T; Maddumage A; Huzaini H; Rich AM; De Silva H; Trudy M; Goonasinghe R; De Silva K; Yasawardena S
Asian Pac J Cancer Prev; 2023 Jan; 24(1):267-274. PubMed ID: 36708576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]